Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
US6531464B1 · kind B1 · utility
27Cited by
21References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2000 |
| Grant date | Mar 11, 2003 |
| Priority date | — |
| Expiry date | Jun 29, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D221/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides a novel class of substituted 6(5H)phenanthridinone compounds. The invention also includes pharmaceutical compositions, and methods of making and using the compounds, or a pharmaceutically acceptable salt, hydrate, prodrug, or mixture thereof. Methods of using the compounds and pharmaceutical compositions for treating neurodegenerative disorders, such as multiple sclerosis are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.